Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Ann Emerg Med. 2010 Aug 21;57(1):1–12. doi: 10.1016/j.annemergmed.2010.05.031

Table 2.

Description of Specific 30-day Adverse Event Outcomes

Adverse Event Category N Frequency
Reason for return visit to ED 124
Shortness of Breath 29 (23%)
Chest Pain 19 (15%)
Palpitations 16 (13%)
Weakness 15 (12%)
Tachycardia 7 (6%)
Altered Mental Status 6 (5%)
Syncope 6 (5%)
Extremity edema 5 (4%)
Cerebrovascular accident (CVA) 4 (3%)
Arrhythmia 4 (3%)
Abdominal Pain 3 (2%)
Abnormal Bleeding 3 (2%)
Hypotension 2 (2%)
Nausea 2 (2%)
Other 3 (2%)
Hospital admission diagnosis 130
AF with rapid ventricular response 42 (32%)
Heart failure 28 (22%)
Chest Pain/Acute coronary syndrome 11 (7%)
Symptomatic AF/atrial flutter 8 (6%)
Shortness of breath/Hypoxia 7 (5%)
CVA/Transient ischemic attack 6 (5%)
Malaise 6 (5%)
Hypotension/Syncope 5 (4%)
Tachycardia 8 (6%)
Bradycardia 4 (3%)
Palpitations 2 (2%)
Acute limb ischemia 1 (1%)
Other 2 (2%)
Cardiovascular complication 128
AF with rapid ventricular response 43 (34%)
Heart Failure 32 (25%)
Embolic complications 10 (8%)
AF with rapid ventricular response and
heart failure
9 (7%)
Acute coronary syndrome 7 (5%)
Atrial flutter with rapid ventricular
response
6 (5%)
Syncope 5 (4%)
Pacemaker dysfunction 4 (3%)
Bradycardia 4 (3%)
Adverse medication reaction 3 (3%)
Cardiac arrest 3 (3%)
Other 2 (2%)
Cause of death 54
Heart Failure 9 (17%)
Intracranial hemorrhage 7 (13%)
Respiratory failure 7 (13%)
Complications of metastatic cancer 7 (13%)
Cardiac arrest 7 (13%)
Sepsis 6 (11%)
Ischemic Stroke 4 (7%))
Thoracic aortic disease 2 (4%)
Pneumonia 2 (4%)
Complications of renal failure 2 (4%)
Myelodysplasia 1 (2%)